無水晶体眼の世界市場規模：タイプ別、治療別、エンドユーザー別、地域別、範囲および予測

無水晶体眼の市場規模と予測

無水晶体眼市場規模は2024年に18億3,000万米ドルと評価され、2031年には43億米ドルに達すると予測され、予測期間2024年～2031年のCAGRは11.3%で成長します。高齢化、急成長するヘルスケア産業、より良い眼疾患治療に対する需要の高まりにより、市場は成長しています。当レポートでは、世界の無水晶体眼市場について包括的な評価を行います。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

世界の無水晶体眼市場の定義

無水晶体眼とは、手術で水晶体を摘出したため、または出生時に水晶体が存在しなかったために、眼球に水晶体が存在しない状態のことです。水晶体は眼球内の透明な構造で、眼球の奥にある網膜に光の焦点を合わせる働きをします。水晶体がないと、視力は著しく損なわれ、重大な視覚障害を引き起こします。無水晶体は、白内障手術、水晶体の先天性欠如、外傷、感染症など、さまざまな原因で生じます。

天然の水晶体を手術で取り除くと、その代わりに人工水晶体を移植することができます。しかし、先天性無水晶体眼のように人工レンズを使用できない場合もあり、視力を改善するために矯正レンズやその他の器具に頼らなければならない場合もあります。無水晶体眼の人は、高度な近視や遠視、乱視などの著しい屈折異常を持つことがよくあります。

視力を改善するために、眼鏡やコンタクトレンズなどの矯正レンズが処方されることがよくあります。場合によっては、無水晶体レンズと呼ばれる特殊なコンタクトレンズが推奨されることもあります。無水晶体眼は視力に大きな影響を与えますが、多くの人は矯正レンズやその他の器具の助けを借りて、通常の生産的な生活を送ることができます。無水晶体眼患者にとって、定期的な眼科検診は視力をモニターし、矯正レンズが最新であることを確認するために重要です。

無水晶体眼の世界市場概要

無水晶体眼市場とは、無水晶体眼として知られる症状の治療に関連する製品やサービスを提供する産業を指します。この市場には、矯正レンズ、人工レンズ、無水晶体眼の人の視力改善に役立つその他の機器などの製品が含まれます。無水晶体眼治療市場は、無水晶体眼の最も一般的な原因である白内障手術の普及率の増加が主な要因となっています。

人口の高齢化と白内障手術件数の増加に伴い、無水晶体眼治療に関連する製品やサービスに対する需要は拡大すると予想されます。無水晶体眼治療市場は、先端技術や革新的な製品の増加によっても牽引されています。例えば、眼内レンズ（IOL）のような新しいタイプの人工レンズの開発により、白内障手術の治療成績が向上し、無水晶体眼患者に新たな選択肢が提供されています。

全体として、無水晶体眼市場は、無水晶体眼および関連疾患の治療オプションに対する需要の増加に伴い、今後も成長し続けると予想されます。技術の新たな革新と進歩が市場を前進させ、無水晶体眼患者の視力と生活の質を向上させる新たな選択肢と機会を提供すると思われます。

市場の魅力

市場の魅力のイメージを提供することで、世界の無水晶体眼科市場をリードしている地域についての情報を得ることができます。我々は、指定された地域における産業の成長を促進する主要な影響要因をカバーしています。

ポーターのファイブフォース

ポーターのファイブフォースフレームワークは、競合他社の行動や各業界におけるプレイヤーの戦略的ポジショニングを理解するための青写真を提供します。ポーターのファイブフォースモデルは、世界の無水晶体市場における競合情勢の評価、特定分野の魅力の測定、投資の可能性の評価に使用することができます。

目次

第1章 無水晶体眼の世界市場：イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界の無水晶体眼市場の展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 無水晶体眼の世界市場：タイプ別

• 概要
• 先天性無水晶体眼
• 手術性無水晶体眼
• 後天性無水晶体眼

第6章 無水晶体眼の世界市場：治療別

• 概要
• 眼鏡
• コンタクトレンズ
• 眼内レンズ挿入術
• 屈折矯正手術

第7章 無水晶体眼の世界市場：エンドユーザー別

• 概要
• 病院
• 眼科クリニック
• その他

第8章 無水晶体眼の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 世界の無水晶体眼市場：競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第10章 企業プロファイル

• Johnson & Johnson Services, Inc.
• Ophtec BV
• Novartis AG
• Bausch Health
• ZEISS International.
• Rayner Intraocular Lenses Limited
• Aetna Inc.
• CooperVision
• Menicon Co.Ltd.
• Labtician Ophthalmics, Inc.

第11章 主な発展

• 製品上市／開発
• 合併と買収
• 事業拡大
• パートナーシップと提携

第12章 付録

• 関連調査

Aphakia Market Size And Forecast

Aphakia Market size was valued at USD 1.83 Billion in 2024 and is projected to reach USD 4.30 Billion by 2031, growing at a CAGR of 11.3% during the forecast period 2024-2031. The market is growing as a result of the aging population, the quickly growing healthcare industry, and the rising demand for better ocular disease treatment. The Global Aphakia Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors playing a substantial role in the market.

Global Aphakia Market Definition

Aphakia is a condition in which a person's eye is missing its natural lens, either because it was surgically removed or because it was never present at birth. The lens is the transparent structure inside the eye that helps to focus light onto the retina at the back of the eye. Without a lens, vision can be severely impaired, causing significant visual problems. Aphakia can result from various causes, including cataract surgery, congenital absence of the lens, trauma, or infection.

When the natural lens is removed surgically, an artificial lens can be implanted to replace it. However, in some cases, such as with congenital aphakia, an artificial lens may not be an option, and the person may need to rely on corrective lenses or other devices to improve their vision. People with aphakia often have significant refractive errors, such as high degrees of nearsightedness or farsightedness, and astigmatism.

Corrective lenses, such as glasses or contact lenses, are often prescribed to help improve vision. In some cases, a special type of contact lens called an aphakic lens may be recommended, which is designed to compensate for the lack of a natural lens. While vision can be significantly affected by aphakia, many people with the condition are able to lead normal, productive lives with the help of corrective lenses or other devices. Regular eye exams are important for people with aphakia to monitor their vision and ensure that their corrective lenses are up to date.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Aphakia Market Overview

The Aphakia Market refers to the industry that provides products and services related to the treatment of the condition known as aphakia, in which a person's natural lens is missing from their eye. The market includes products such as corrective lenses, artificial lenses, and other devices that can help improve vision in people with aphakia. The market for aphakia treatment is primarily driven by the increasing prevalence of cataract surgery, which is the most common cause of aphakia.

As the population ages and the number of cataract surgeries performed increases, the demand for products and services related to aphakia treatment is expected to grow. The market for aphakia treatment is also driven by the increasing availability of advanced technology and innovative products. For example, the development of new types of artificial lenses, such as intraocular lenses (IOLs), has improved the outcomes of cataract surgery and provided new options for people with aphakia.

Overall, the Aphakia Market is expected to continue to grow in the coming years as the demand for treatment options for aphakia and related conditions increases. New innovations and advancements in technology are likely to drive the market forward, providing new options and opportunities for people with aphakia to improve their vision and quality of life.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Aphakia Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter's Five Forces

The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Aphakia Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Global Aphakia Market Segmentation Analysis

The Global Aphakia Market is segmented on the basis of Type, Treatment, End User, and Geography.

Aphakia Market, By Type

• Congenital Aphakia
• Surgical Aphakia
• Acquired Aphakia

Based on Type, the Aphakia Market is segmented into Congenital Aphakia, Surgical Aphakia, and Acquired Aphakia. Acquired Aphakia is a condition brought on by the absence of eye lenses. This disorder can affect people of any age, but it usually develops as a result of an accident, a procedure, or an illness such as osteogenesis imperfecta or glaucoma. Patients without a lens or its remnant are reported to have this kind of aphakia. Double vision and hazy vision are two of the signs of this type, while additional signs include cataract surgery, refractive surgery, etc.

Aphakia Market, By Treatment

• Spectacles
• Contact Lenses
• Intraocular Lens Implantation
• Refractive Surgery

Based on Treatment, the Aphakia Market is segmented into Spectacles, Contact Lenses, Intraocular Lens Implantation, and Refractive Surgery. When the natural lens of an eye gets foggy and cannot be corrected by regular glasses, aphakia is employed. This allows for a clean vision of objects that are different distances from the eyes. Once such treatment has been received, an aphakia patient will no longer require the use of any extra reading or near-vision lenses.

Aphakia Market, By End User

• Hospitals
• Ophthalmic clinics
• Others

Based on End User, the Aphakia Market is segmented into Hospitals, Ophthalmic clinics, and Others.

Aphakia Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
• On the basis of Regional Analysis, The Global Aphakia Market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Due to the rising prevalence of aphakia cases, advanced technology, the region's sizable diabetic population, and increased government funding for R&D, North America dominates the global aphakia industry. Because of its substantial and fast-expanding economy, sizable patient pool, rising frequency of ocular illnesses, and rapidly rising elderly population, Asia-Pacific is predicted to develop at a significant growth rate in the forecast period.

Key Players

• The "Global Aphakia Market" study report will provide valuable insight with an emphasis on the Global market including some of the major key players such as
• Johnson & Johnson Services, Inc., Ophtec BV, Novartis AG, Bausch Health, ZEISS International, Rayner Intraocular Lenses Limited, Aetna Inc., CooperVision, Menicon Co., Ltd., Labtician Ophthalmics, Inc., and Others.

Our market analysis contains a section exclusively devoted to such significant firms, where our experts provide a summary of each company's financial statements as well as product benchmarking and SWOT analysis. The competitive landscape section also includes the key development strategies, market share analysis, and market positioning analysis of the aforementioned competitors internationally.

Key Developments

• In July 2022, Intraocular lenses (IOLs) from the Clareon(R)family have been made available in the United States, according to Alcon (SIX/NYSE: ALC), a leader in eye care around the world committed to enabling people to see brilliantly. The most cutting-edge IOL material from Alcon allows Clareon to produce consistently excellent visual results and long-lasting clarity. 1-7 When compared to the leading competitor IOLs, the glistening-free IOL material used in Clareon has some of the lowest levels of haze and subsurface nanoglistenings (SSNGs).
• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as
• Active, Cutting Edge, Emerging, and Innovators.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL APHAKIA MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL APHAKIA MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL APHAKIA MARKET, BY TYPE

• 5.1 Overview
• 5.2 Congenital Aphakia
• 5.3 Surgical Aphakia
• 5.4 Acquired Aphakia

6 GLOBAL APHAKIA MARKET, BY TREATMENT

• 6.1 Overview
• 6.2 Spectacles
• 6.3 Contact Lenses
• 6.4 Intraocular Lens Implantation
• 6.5 Refractive Surgery

7 GLOBAL APHAKIA MARKET, BY END USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Ophthalmic Clinics
• 7.4 Others

8 GLOBAL APHAKIA MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL APHAKIA MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Johnson & Johnson Services, Inc.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Ophtec BV
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Novartis AG
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Bausch Health
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 ZEISS International.
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Rayner Intraocular Lenses Limited
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Aetna Inc.
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 CooperVision
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Menicon Co.Ltd.
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Labtician Ophthalmics, Inc.
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1 Related Research